2-Hydroxy-3-nitro-6-(trifluoromethyl)pyridine, 95.0%, 1g

1-(3-Chloro-4-methylphenyl)-3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)urea, 97.00%, 250mg

2,6-Di(1-pyrazolyl)pyridine>98.0%(GC)5g

(R)-1,4-Dibenzyl-2-(chloromethyl)piperazine, 98%, 100mg

2-(2-Naphthyloxy)propanohydrazide, 95.0%, 5g

5-amino-N,1-dimethyl-1H-pyrazole-4-carboxamide, 95.0%, 25g

tert-Butyl 4-oxo-3-azatricyclo[4.2.1.02,5]non-7-ene-3-carboxylate, 95%, 2g

4-Bromo-1,2-bis(bromomethyl)benzene, 95.0%, 25g

(4-CHLORO-PHENYL)-MORPHOLIN-4-YL-ACETIC ACID HCL, 95.0%, 250mg

1,3-Bis[4-(2-pyridyl)-2-thiazolyl]benzene, 1g

beta-D-Gentiobiose, min. 98 %, für die Biochemie, 250 mg, Glasverpackung

N,N-Dimethylacetamide Dimethyl Acetal (stabilized with 5-10% Methanol)>90.0%(T)25mL

4-Hydroxyisophthalic acid, 95.0%, 5g